[XENE] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
01-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -65.52%
YoY- -107.45%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 132 536 8,766 3,737 8,124 2,218 4,358 -90.26%
PBT -37,737 -31,198 -20,064 -25,080 -15,650 -22,326 -15,832 78.34%
Tax -587 -40 -394 484 -205 -217 -68 320.25%
NP -37,150 -31,158 -19,670 -25,564 -15,445 -22,109 -15,764 76.99%
Tax Rate - - - - - - - -
Total Cost 37,282 31,694 28,436 29,301 23,569 24,327 20,122 50.79%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -28,143.94 -5,813.06 -224.39 -684.08 -190.12 -996.80 -361.73 1717.67%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.59 -0.55 -0.37 -0.62 -0.37 -0.53 -0.43 23.45%
EPS Diluted -0.57 -0.55 -0.36 -0.62 -0.37 -0.53 -0.43 20.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.